Open AccessMetabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study
Author(s) -
Feng Qian,
LiangJie Tang,
Dinghai Luo,
Ying Wang,
Nan Wu,
Hao Chen,
Mengxia Chen,
Lei Jiang,
Rong Jin
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s338783
Subject(s) - hyperuricemia , medicine , metabolic syndrome , hazard ratio , colorectal cancer , proportional hazards model , gastroenterology , retrospective cohort study , cancer , multivariate analysis , uric acid , confidence interval , obesity
Hyperuricemia and metabolic syndrome (MetS) have been shown to correlate with prognosis in patients with malignant tumors. The present study evaluated the relationship between preoperative hyperuricemia and MetS in colorectal cancer (CRC) patients and analyzed the effect of this combination on prognosis within 5 years.